BioMed Research International

BioMed Research International / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 7686249 | 2 pages | https://doi.org/10.1155/2017/7686249

Corrigendum to “Chitosan Prevents Gentamicin-Induced Nephrotoxicity via a Carbonyl Stress-Dependent Pathway”

Received13 Aug 2017
Accepted17 Aug 2017
Published24 Sep 2017

In the article titled “Chitosan Prevents Gentamicin-Induced Nephrotoxicity via a Carbonyl Stress-Dependent Pathway” [1], the name of the first author was given incorrectly as Chu-Kung Chou. The author’s name should have been written as Chu-Kuang Chou. The revised authors’ list is shown above.

Also, there was an error in Figure . Figures (b) and (e) were inadvertently reused from Yi-Chieh Li, Yi-Min Shih, and Jen-Ai Lee, “Gentamicin caused renal injury deeply related to methylglyoxal and Nɛ-(carboxyethyl)lysine (CEL),” Toxicology Letters, Volume 219, Issue 1, https://www.doi.org/10.1016/j.toxlet.2013.01.024. Additionally, the same picture of Figure (e) was presented as Figure (c). The corrected Figure 2 is as follows.

References

  1. C.-K. Chou, Y.-C. Li, S.-M. Chen, Y.-M. Shih, and J.-A. Lee, “Chitosan prevents gentamicin-induced nephrotoxicity via a carbonyl stress-dependent pathway,” BioMed Research International, vol. 2015, Article ID 675714, 8 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2017 Chu-Kuang Chou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

416 Views | 211 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.